Microencapsulated Genetically EngineeredLactobacillus plantarum80 (pCBH1) for Bile Acid Deconjugation and Its Implication in Lowering Cholesterol
about
Cholesterol-lowering probiotics as potential biotherapeutics for metabolic diseasesInvestigation of microencapsulated BSH active lactobacillus in the simulated human GI tractProbiotics and Prebiotics: Present Status and Future Perspectives on Metabolic DisordersInvestigation of Genipin Cross-Linked Microcapsule for Oral Delivery of Live Bacterial Cells and Other Biotherapeutics: Preparation and In Vitro Analysis in Simulated Human Gastrointestinal ModelCharacterization of Bile Salt Hydrolase from Lactobacillus gasseri FR4 and Demonstration of Its Substrate Specificity and Inhibitory Mechanism Using Molecular Docking Analysis.Cholesterol-lowering effects of probiotics and prebiotics: a review of in vivo and in vitro findings.Oral microencapsulated live Saccharomyces cerevisiae cells for use in renal failure uremia: preparation and in vivo analysis.Inflammatory bowel disease: clinical aspects and treatments.Bile salt hydrolase activity in probiotics.The human microbiome is a source of therapeutic drug targets.Safety assessment of Bifidobacterium longum JDM301 based on complete genome sequences.Genes involved in obesity: Adipocytes, brain and microfloraFeeding our immune system: impact on metabolism.Bacterial biofilms associated with food particles in the human large bowel.Therapeutic modulation of microbiota-host metabolic interactions.Probiotics--interactions with bile acids and impact on cholesterol metabolism.Microencapsulation for the Therapeutic Delivery of Drugs, Live Mammalian and Bacterial Cells, and Other Biopharmaceutics: Current Status and Future Directions.Characterization of lactobacilli isolated from caper berry fermentations.Gut microbiota as a potential target of metabolic syndrome: the role of probiotics and prebiotics.Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis.An in vivo assessment of the cholesterol-lowering efficacy of Lactobacillus plantarum ECGC 13110402 in normal to mildly hypercholesterolaemic adults.Investigation of the Protective Effect of Kefir against Isoproterenol Induced Myocardial Infarction in Rats.Efficacy of Lactobacillus plantarum in prevention of inflammatory bowel disease.Effects of Probiotics, Prebiotics, and Synbiotics on Hypercholesterolemia: A Review
P2860
Q21285153-3CA72F6A-0191-4F37-A53F-1D115A83ABB5Q21343017-17C5EED3-1086-4A45-B7C7-3F01D3C6CD33Q26752979-DB35D978-D460-4C77-A6A4-0282B0170C05Q27495930-32738F0D-B3D6-4F02-94DB-52C5A55EFF90Q33741295-27DB00EB-1A12-41FA-A9B8-8B99DB3CDAF2Q33998828-230B1236-3942-47DE-9787-D6611601B6D4Q34080384-377B1136-49F9-4DFE-BA9E-436ED4C00073Q34431476-8C93AFA9-6A61-438B-ACD2-C04190865DC7Q34432358-7D7EA306-9B55-4B1A-9060-2360456681CAQ34726528-7183BB5E-B364-49CB-9695-2A6608D0903CQ35725903-A0765C2F-E585-49DD-84EA-8AD48050799CQ36267948-186AE1A3-EFF1-417D-B711-735DA5AE3DA6Q36494499-23B9CF46-0491-4336-880B-6B8F6C41FE8DQ37884523-008BD27C-30AA-459E-9BFB-B96E6A5F5B85Q38016806-FF568303-EA7B-4AED-80CA-60889CCD8C9FQ38051231-7EDD46E8-F333-4432-8AC7-CAE9AD5C7495Q38629901-984CA1A5-B270-4E71-94DC-47786CF5A6FBQ40249786-A87A74B4-1F21-4389-8576-DA54780AE4CCQ47117314-A2EDC99B-C38B-4218-92B1-E0836159E355Q47668921-432DD773-D4F6-48EC-A2ED-9CBC84C59F47Q48141171-FE2386D2-EEA2-44E3-A1E7-4A2C182B5BE4Q54978050-6FEC5049-DA8E-40DA-B1E3-80B960B9F795Q55152165-081C4CD2-9F37-4868-8714-A7957FE1BC5FQ59050070-4A67E870-0035-4F6E-B411-5E395F3134BD
P2860
Microencapsulated Genetically EngineeredLactobacillus plantarum80 (pCBH1) for Bile Acid Deconjugation and Its Implication in Lowering Cholesterol
description
2004 nî lūn-bûn
@nan
2004 թուականին հրատարակուած գիտական յօդուած
@hyw
2004 թվականին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Microencapsulated Genetically ...... cation in Lowering Cholesterol
@ast
Microencapsulated Genetically ...... cation in Lowering Cholesterol
@en
Microencapsulated Genetically ...... cation in Lowering Cholesterol
@nl
type
label
Microencapsulated Genetically ...... cation in Lowering Cholesterol
@ast
Microencapsulated Genetically ...... cation in Lowering Cholesterol
@en
Microencapsulated Genetically ...... cation in Lowering Cholesterol
@nl
prefLabel
Microencapsulated Genetically ...... cation in Lowering Cholesterol
@ast
Microencapsulated Genetically ...... cation in Lowering Cholesterol
@en
Microencapsulated Genetically ...... cation in Lowering Cholesterol
@nl
P2093
P2860
P1476
Microencapsulated Genetically ...... cation in Lowering Cholesterol
@en
P2093
Hongmei Chen
Mitchell Lawrence Jones
Satya Prakash
Terrence Metz
Wei Ouyang
P2860
P356
10.1155/S1110724304307011
P577
2004-01-01T00:00:00Z